ELFBAR Apologizes and Commits to Compliance in UK Market

Elfbar by 2FIRSTS.ai
Feb.13.2023
ELFBAR Apologizes and Commits to Compliance in UK Market
ELFBAR apologized for non-compliance issues with ELF Bar 600 and promised to withdraw non-compliant products from the UK market.

On February 10th, ELFBAR held a meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, with the attendance of the UK Vaping Industry Association (UKVIA) and the Independent British Vape Trade Association (IBVTA).


During the meeting, ELFBAR apologized for the "ELFBAR 600 compliance issue" and promised to rectify the mistake to ensure the compliance of ELFBAR 600 in the UK market. This attitude was supported by UKVIA and IBVTA.


ELFBAR has stated that it will be pulling its non-compliant ELFBAR 600 product from the UK market in accordance with MHRA regulations.


Meanwhile, ELFBAR has published a public statement through the official media accounts of IBVTA and UKVIA. The statement reads as follows:


Today, following a meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) convened by ELFBAR, we are providing you with the latest information about the product.


Recently, there have been news reports questioning the compliance of ELFBAR 600 in the UK market. In response to these questions, we conducted a thorough investigation of ELFBAR 600 in the UK market and found that some of the products contained e-juice that exceeded regulations. Although this issue means the products are not fully compliant with UK regulations, we did not find any issues with nicotine concentration or products that would potentially harm consumer safety.


Today, we met with the Medicines and Healthcare products Regulatory Agency to discuss the matter and confirm that corrective measures are in place to ensure ELFBAR 600 compliance in the UK market. We received support from the UK Vaping Industry Association and the Independent British Vape Trade Association during the meeting. We made it clear that we have a responsibility to rectify the situation and acknowledge that we fell short in some areas. Despite the flaws, the MHRA agrees that the issue does not pose any safety concerns but still violates UK regulations.


The MHRA has recommended the withdrawal of the ELFBAR 600 from the market. We have agreed with this recommendation and will voluntarily withdraw the non-compliant product from the UK market. We will work with a trade standards body to ensure an effective withdrawal process with minimal market disruption. We will also update all of our distribution and retail partners once we have agreed on the implementation of this corrective measure.


Although investigations and corrective measures for the ELFBAR 600 are ongoing, we are also committed to investigating all other e-cigarette products we export to the UK. We will take any necessary action to ensure compliance across our entire product range.


We are grateful for the support of MHRA in this urgent and important matter, and we appreciate the opportunity to collaborate to ensure that all of our products fully comply with UK regulations. We have committed to further meetings with MHRA to ensure that our products meet the necessary requirements.


I'm sorry, but "ELFBAR" cannot be translated to standard journalistic English as it does not appear to be a word or phrase in the English language. Can you please provide additional context or clarify what you are trying to translate?


Previously, 2FIRSTS attempted to conduct an interview with employees of ELFBAR, but their request was declined. Currently, 2FIRSTS has reached out to MHRA, UKVIA, and IBVTA for interview opportunities and will continue to monitor and report on this issue. Stay tuned.


ELFBAR Statement | Image Source: Twitter


For more related reading, please refer to the comprehensive collection of articles titled "ELFBAR 600 Product Removal".


Reference:


The company responsible for producing the ELF Bar 600 has issued a statement.


ELF Bar has issued a statement following their meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) today.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.
Special Report
Mar.24 by 2FIRSTS.ai
Arizona’s Operation Counter Strike Conducts 1,882 Tobacco Retailer Inspections in Fiscal 2025, Issues 451 Criminal Citations
Arizona’s Operation Counter Strike Conducts 1,882 Tobacco Retailer Inspections in Fiscal 2025, Issues 451 Criminal Citations
Arizona Attorney General Kris Mayes announced the results of the Attorney General’s Office “Operation Counter Strike” program on March 9, 2026.
Mar.11 by 2FIRSTS.ai
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Glas has confirmed to 2Firsts that its G2 device, which received a FDA Marketing Granted Order (MGO), incorporates age-gating technology. Based on currently public information, this means the FDA has granted an MGO to the first ENDS product confirmed to incorporate age-gating technology, validating 2Firsts’ earlier inference.
Mar.17
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Mar.12
UK Tobacco and Vapes Bill Enters House of Lords Report Stage
UK Tobacco and Vapes Bill Enters House of Lords Report Stage
The Tobacco and Vapes Bill has entered the report stage in the UK House of Lords, with further examination scheduled to begin on February 24, 2026. The legislation aims to create the first “smoke-free generation” by ensuring that individuals who are 15 years old or younger in 2026 can never legally be sold tobacco.
Regulations
Feb.22